These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 7677113

  • 1. Laboratory assessment of von Willebrand factor. Use of different assays can influence the diagnosis of von Willebrand's disease, dependent on differing sensitivity to sample preparation and differential recognition of high molecular weight VWF forms.
    Favaloro EJ, Facey D, Grispo L.
    Am J Clin Pathol; 1995 Sep; 104(3):264-71. PubMed ID: 7677113
    [Abstract] [Full Text] [Related]

  • 2. Laboratory assays for von Willebrand factor: relative contribution to the diagnosis of von Willebrand's disease.
    Favaloro EJ, Koutts J.
    Pathology; 1997 Nov; 29(4):385-91. PubMed ID: 9423220
    [Abstract] [Full Text] [Related]

  • 3. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
    Favaloro EJ, Smith J, Petinos P, Hertzberg M, Koutts J.
    Thromb Haemost; 1999 Oct; 82(4):1276-82. PubMed ID: 10544913
    [Abstract] [Full Text] [Related]

  • 4. Von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: a 15-year journey.
    Favaloro EJ.
    Semin Thromb Hemost; 2002 Apr; 28(2):191-202. PubMed ID: 11992242
    [Abstract] [Full Text] [Related]

  • 5. von Willebrand's disease: use of collagen binding assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy.
    Favaloro EJ, Dean M, Grispo L, Exner T, Koutts J.
    Am J Hematol; 1994 Mar; 45(3):205-11. PubMed ID: 8296790
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Discrimination of von Willebrands disease (VWD) subtypes: direct comparison of von Willebrand factor:collagen binding assay (VWF:CBA) with monoclonal antibody (MAB) based VWF-capture systems.
    Favaloro EJ, Henniker A, Facey D, Hertzberg M.
    Thromb Haemost; 2000 Oct; 84(4):541-7. PubMed ID: 11057847
    [Abstract] [Full Text] [Related]

  • 8. Laboratory assessment of von Willebrand factor: differential influence of prolonged ambient temperature specimen storage on assay results.
    Favaloro EJ, Mehrabani PA.
    Haemophilia; 1996 Oct; 2(4):218-23. PubMed ID: 27214360
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA, Blanchette VS, Carcao MD, Stain AM, Sparling CR, Siekmann J, Turecek PL, Lillicrap D, Rand ML.
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay.
    Riddell AF, Jenkins PV, Nitu-Whalley IC, McCraw AH, Lee CA, Brown SA.
    Br J Haematol; 2002 Jan; 116(1):187-92. PubMed ID: 11841416
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Performance and clinical utility of a commercial von Willebrand factor collagen binding assay for laboratory diagnosis of von Willebrand disease.
    Popov J, Zhukov O, Ruden S, Zeschmann T, Sferruzza A, Sahud M.
    Clin Chem; 2006 Oct; 52(10):1965-7. PubMed ID: 16887898
    [Abstract] [Full Text] [Related]

  • 15. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
    Vanhoorelbeke K, Cauwenberghs N, Vandecasteele G, Vauterin S, Deckmyn H.
    Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
    [Abstract] [Full Text] [Related]

  • 16. Differential sensitivity of von Willebrand factor (VWF) 'activity' assays to large and small VWF molecular weight forms: a cross-laboratory study comparing ristocetin cofactor, collagen-binding and mAb-based assays.
    Favaloro EJ, Bonar R, Chapman K, Meiring M, Funk Adcock D.
    J Thromb Haemost; 2012 Jun; 10(6):1043-54. PubMed ID: 22487084
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL, Siekmann J, Schwarz HP.
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.